Drug approvals bounce back as R & D labs churn out new winners

LONDON (Reuters) - The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.

Source: Reuters: Health - May 25, 2017 Category: Consumer Health News Tags: healthNews Source Type: news